[Cytomegalovirus retinitis in AIDS. Treatment with intravitreal injections of ganciclovir]. 1990

I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
Service d'Ophtalmologie, Hôpital La Pitié-Salpêtrière, Paris.

Cytomegalovirus (CMV) retinitis is the most frequent ocular infection in AIDS, and it is responsible for blindness. Intravitreal injections of ganciclovir in doses of 400 g have been tried in patients who could not tolerate any systemic treatment. Induction therapy consists of 2 injections per week, followed by maintenance therapy with 1 injection per week. The present study involved 17 patients. Twenty-three induction courses could be evaluated; all had a favourable response with an average of 6 injections per eye. Seventeen maintenance courses were evaluated, with a mean of 5 injections per eye. There was no relapse in 10 eyes (70 percent) at 48 days. There was no evidence of toxicity from repeated intravitreal injections: no cataract, retinal detachment or endophthalmitis was observed with a total of 231 injections. Intravitreal ganciclovir appears to be an effective local treatment of CMV retinitis in AIDS patients when systemic therapy cannot be used.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012173 Retinitis Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis). Neuroretinitis
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592

Related Publications

I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
November 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
January 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
April 1996, Revista clinica espanola,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
May 1988, Ophthalmology,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
January 2019, International journal of ophthalmology,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
January 1996, The Annals of pharmacotherapy,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
January 1992, The Annals of pharmacotherapy,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
August 1996, Nippon Ganka Gakkai zasshi,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
July 1996, American journal of ophthalmology,
I Cochereau-Massin, and P Le Hoang, and M Lautier-Frau, and L Zazoun, and P Marcel, and M Robinet, and A Besingue, and F Rousselie
August 1992, Ophthalmology,
Copied contents to your clipboard!